pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
elraglusib
Neuroblastoma
Glycogen synthase kinase-3 beta
$ACTU
ACTUATE THERAPEUTICS, INC.
0
catalysts
Phase 3
elritercept
Anemia
$TAK
TAKEDA PHARMACEUTICAL CO LTD
0
catalysts
Phase 3
elsunersen
elsunersen [INN]
Epileptic Encephalopathy
$PRAX
Praxis Precision Medicines, Inc.
catalysts
← prev
page 207 of 271
next →
131
Pain
89
Neurology
1
0
Phase 1
eltanolone
eltanolone [INN]
Epilepsy
$LPCN
Lipocine Inc.
0
catalysts
Phase 2
eltivutabart
eltivutabart [INN]
Pancreatic Ductal Adenocarcinoma
Trishula Therapeutics Inc
0
catalysts
Phase 2
elunetirom
Bipolar I Disorder
Autobahn Therapeutics Inc
0
catalysts
Marketed
eluxadoline
Viberzi (eluxadoline)
Diarrhea
$ABBV
AbbVie Inc.
0
catalysts
Phase 2
elzovantinib
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
0
catalysts
Phase 3
emactuzumab
Tenosynovial Giant Cell Tumor
Macrophage colony-stimulating factor 1 receptor
SynOx Therapeutics Ltd
0
catalysts
Marketed
emapalumab
Gamifant (emapalumab-lzsg)
Hemophagocytic Lymphohistiocytosis
Sobi Inc
0
catalysts
Phase 1
emaretamig
emaretamig [INN]
Adenocarcinoma Of The Gastroesophageal Junction
$XNCR
Xencor Inc
0
catalysts
Phase 3
emestedastat
Xanamem (emestedastat)
Alzheimer's Disease
Actinogen Medical Ltd
0
catalysts
Phase 2
emicizumab
Hemlibra (emicizumab-kxwh)
Acquired Hemophilia A
Coagulation factor IX and X
Chugai Pharmaceutical Co Ltd
0
catalysts
Phase 1
emiltatug ledadotin
emiltatug ledadotin [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$DAWN
Day One Biopharmaceuticals, Inc.
0
catalysts
Phase 3
emixustat hydrochloride
Juvenile Macular Degeneration (Stargardt Disease)
Retinoid isomerohydrolase
Kubota Vision Inc
0
catalysts
Phase 2
emodepside
Onchocerciasis (River Blindness)
Bayer AG
0
catalysts
Phase 3
empagliflozin
Jardiance (empagliflozin)
Diastolic Heart Failure (HFpEF)
Sodium/glucose cotransporter 2
Boehringer Ingelheim International GmbH
0
catalysts
Phase 3
empasiprubart
Multifocal Motor Neuropathy
$ARGX
ARGENX SE
0
catalysts
Phase 2
emraclidine
Psychosis
$ABBV
AbbVie Inc.
0
catalysts
Phase 2
emrusolmin
emrusolmin [INN]
Multiple System Atrophy (Multi-System Degeneration)
$TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
0
catalysts
Phase 2
emugrobart
emugrobart [INN]
Obesity
F. Hoffmann-La Roche Ltd
0
catalysts
Phase 1
emunkitug
emunkitug [INN]
Cervical Cancer
HiFiBiO Therapeutics Inc
0
catalysts
Marketed
enalapril maleate
Enalapril Maleate Oceanside (enalapril maleate)
Congestive Heart Failure (Heart Failure)
Oceanside Pharmaceuticals Inc
0
catalysts
Marketed
enalaprilat
Enalaprilat (enalaprilat)
Hypertension
Dr. Reddy's Laboratories Ltd
0
catalysts
Phase 2
enamptcumab
eNamptor
Acute Respiratory Distress Syndrome
Aqualung Therapeutics Corp
0
catalysts
Marketed
enasidenib mesylate
Idhifa (enasidenib mesylate)
Refractory Acute Myeloid Leukemia
Bristol-Myers Squibb Co
0
catalysts
Phase 3
encaleret
Autosomal Dominant Hypocalcemia
$BBIO
BridgeBio Pharma, Inc.
0
catalysts
Phase 2
encoberminogene rezmadenovec
Refractory Angina
XyloCor Therapeutics Inc
0
catalysts
Phase 2
endoxifen
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$ATOS
ATOSSA THERAPEUTICS, INC.
0
catalysts
Phase 3
eneboparatide
Hypoparathyroidism
Alexion Pharmaceuticals Inc
0
catalysts
